AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
317 hedge funds and large institutions have $3.47B invested in Amedisys in 2019 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 117 increasing their positions, 107 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
4.06% less ownership
Funds ownership: 92.17% → 88.11% (-4.1%)
61% less call options, than puts
Call options by funds: $10.3M | Put options by funds: $26.4M
Holders
317
Holding in Top 10
–
Calls
$10.3M
Puts
$26.4M
Top Buyers
| 1 | +$22M | |
| 2 | +$20.2M | |
| 3 | +$18.3M | |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$13.1M |
| 5 |
Two Sigma Advisers
New York
|
+$12.7M |
Top Sellers
| 1 | -$102M | |
| 2 | -$33.9M | |
| 3 | -$31M | |
| 4 |
Morgan Stanley
New York
|
-$28.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15.9M |